US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lakefront Biotherapeutics

29.04

+0.24000.83%

Post-market: 29.040.00000.00%16:10 EDT

Volume:123.41K

Turnover:3.55M

Market Cap:1.91B

PE:2.82

High:29.06

Open:28.66

Low:28.33

Close:28.80

52wk High:37.78

52wk Low:25.68

Shares:65.90M

Float Shares:23.98M

Volume Ratio:0.39

T/O Rate:0.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):10.31

EPS(LYR):5.72

ROE:20.12%

ROA:9.93%

PB:0.50

PE(LYR):5.08

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Lakefront Biotherapeutics

Exchange:

NASDAQ

Establishment Date:

1999

Employees:

196

Office Location:

SchaliEnhoevedreef 20 T,Mechelen,Antwerp,Belgium

Website:

http://www.glpg.com

Zip Code:

2800

Phone:

Fax:

32 1 534 29 01

Introduction:

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Directors

Name

Position

Henry Gosebruch

Chief Executive Officer and Director

Jerome Contamine

Chair of the Board

Dawn Svoronos

Director

Devang Bhuva

Director

Jane Griffiths

Director

Linda Higgins

Director

Neil Johnston

Director

Oleg Nodelman

Director

Shareholders

Name

Position

Henry Gosebruch

Chief Executive Officer and Director

Aaron Cox

Chief Financial Officer and Executive Vice President

Annelies Missotten

Chief Human Resources Officer and Executive Vice President

Eric Hedrick

Chief Medical Officer

Fred Blakeslee

Executive Vice President and General Counsel

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LKFT/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LKFT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LKFT\",,,,,undefined,":{"symbol":"LKFT","market":"US","secType":"STK","nameCN":"Lakefront Biotherapeutics","latestPrice":29.04,"timestamp":1787601600000,"preClose":28.8,"halted":0,"volume":123407,"hourTrading":{"tag":"盘后","latestPrice":29.04,"preClose":29.04,"latestTime":"16:10 EDT","volume":945,"amount":27443.60325,"timestamp":1787602205303,"change":0,"changeRate":0,"amplitude":0.000689},"delay":0,"changeRate":0.00833333333333328,"floatShares":23979200,"shares":65897071,"eps":10.306208,"marketStatus":"Post-Mkt","change":0.24,"latestTime":"08-24 17:54:50 EDT","open":28.66,"high":29.06,"low":28.33,"amount":3548358,"amplitude":0.025347,"askPrice":32.48,"askSize":100,"bidPrice":23.59,"bidSize":100,"shortable":3,"etf":0,"ttmEps":10.306208,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1431576000000,"exchange":"NASDAQ","adjPreClose":28.8,"preHourTrading":{"tag":"盘前","latestPrice":28.65,"preClose":28.8,"latestTime":"09:29 EDT","volume":1123,"amount":32125.64977,"timestamp":1787578170007,"change":-0.15,"changeRate":-0.005208,"amplitude":0.006944},"postHourTrading":{"tag":"盘后","latestPrice":29.04,"preClose":29.04,"latestTime":"16:10 EDT","volume":945,"amount":27443.60325,"timestamp":1787602205303,"change":0,"changeRate":0,"amplitude":0.000689},"volumeRatio":0.390647,"impliedVol":0.449,"impliedVolPercentile":0.8919},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LKFT\",,,,,undefined,":{"symbol":"LKFT","floatShares":23979200,"roa":"9.93%","roe":"20.12%","lyrEps":5.717976,"volumeRatio":0.390647,"shares":65897071,"dividePrice":0,"high":29.06,"amplitude":0.025347,"preClose":28.8,"low":28.33,"week52Low":25.68,"pbRate":"0.50","psRate":"1.66","week52High":37.78,"institutionHeld":0,"latestPrice":29.04,"eps":10.306208,"divideRate":0,"volume":123407,"delay":0,"ttmEps":10.306208,"open":28.66,"prevYearClose":32.7,"prevWeekClose":28.8,"prevMonthClose":27.21,"prevQuarterClose":29.98,"fiveDayClose":27.52,"twentyDayClose":28.13,"sixtyDayClose":28.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LKFT\",params:#limit:5,,,undefined,":[{"date":"2026-08-10","symbol":"LKFT","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786392000000,"name":null,"time":"Post-Mkt","dateTimestamp":1786334400000,"actualEps":null},{"market":"US","date":"2026-05-06","symbol":"LKFT","fiscalQuarterEnding":"2026/03","expectedEps":-1.27,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.25},{"date":"2026-02-23","symbol":"LKFT","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":1,"defaultRemindTime":1771880400000,"name":null,"time":"Post-Mkt","dateTimestamp":1771822800000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"LKFT","fiscalQuarterEnding":"2025/09","expectedEps":-0.17,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-07-23","symbol":"LKFT","fiscalQuarterEnding":"2025/06","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1753243200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LKFT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LKFT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.6,"sell":0,"strongSell":0.2,"meanLabel":"HOLD","meanPercent":0.6,"analysts":5,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LKFT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LKFT","date":"2026-08-21","current":2.794432,"percent":0.042857,"low":2.631093,"twenty":3.146693,"median":3.268031,"eighty":3.464868,"high":3.621259,"avg":3.243293,"sd":0.255363,"marketCap":1866440976.41},"quantilePoints":[{"date":"2026-05-15","current":3.154783,"twenty":3.153704,"median":3.154783,"eighty":3.214103,"marketCap":1799919996.5},{"date":"2026-05-22","current":3.203318,"twenty":3.140222,"median":3.161524,"eighty":3.209789,"marketCap":1814059096.28},{"date":"2026-05-29","current":3.297692,"twenty":3.152626,"median":3.204666,"eighty":3.248617,"marketCap":1878385218.51},{"date":"2026-06-05","current":3.289602,"twenty":3.154783,"median":3.206014,"eighty":3.248617,"marketCap":1869203129.5},{"date":"2026-06-12","current":3.362405,"twenty":3.156401,"median":3.219496,"eighty":3.286367,"marketCap":1893838384.42},{"date":"2026-06-18","current":3.31387,"twenty":3.161793,"median":3.24646,"eighty":3.307399,"marketCap":1859003793.18},{"date":"2026-06-26","current":3.464868,"twenty":3.177972,"median":3.251853,"eighty":3.357012,"marketCap":1927999458.11},{"date":"2026-07-02","current":3.551153,"twenty":3.194689,"median":3.268031,"eighty":3.402851,"marketCap":1986414339.67},{"date":"2026-07-10","current":3.548456,"twenty":3.203857,"median":3.293647,"eighty":3.464868,"marketCap":1982637069.04},{"date":"2026-07-17","current":3.505314,"twenty":3.206553,"median":3.31387,"eighty":3.504775,"marketCap":1960100498.8},{"date":"2026-07-24","current":3.303084,"twenty":3.209789,"median":3.339486,"eighty":3.496686,"marketCap":1835677361},{"date":"2026-07-31","current":3.2168,"twenty":3.214103,"median":3.321959,"eighty":3.472957,"marketCap":1810159007.6},{"date":"2026-08-07","current":3.146693,"twenty":3.192532,"median":3.308477,"eighty":3.472957,"marketCap":1772341135.05},{"date":"2026-08-14","current":2.63993,"twenty":3.157479,"median":3.293647,"eighty":3.464868,"marketCap":1816958924.78},{"date":"2026-08-21","current":2.678428,"twenty":3.146693,"median":3.268031,"eighty":3.464868,"marketCap":1866440976.41}],"updateTime":1787570237293},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1716658,"yearFounded":1999,"employeeNum":196,"address":"SchaliEnhoevedreef 20 T,Mechelen,Antwerp,Belgium","zipCode":"2800","officePhone":"32 1 534 29 00","officeFax":"32 1 534 29 01","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.glpg.com","stockEarnings":[{"period":"1week","weight":0.0461},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.0477},{"period":"6month","weight":-0.1472},{"period":"1year","weight":-0.0977},{"period":"ytd","weight":-0.1193}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.029049},{"month":2,"riseRate":0.181818,"avgChangeRate":-0.055722},{"month":3,"riseRate":0.363636,"avgChangeRate":0.000347},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.006786},{"month":5,"riseRate":0.454545,"avgChangeRate":0.029994},{"month":6,"riseRate":0.25,"avgChangeRate":-0.031196},{"month":7,"riseRate":0.583333,"avgChangeRate":0.055398},{"month":8,"riseRate":0.25,"avgChangeRate":-0.022918},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.018717},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.009712},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.004236},{"month":12,"riseRate":0.727273,"avgChangeRate":0.051262}],"exchange":"NASDAQ","name":"Lakefront Biotherapeutics","nameEN":"Lakefront Biotherapeutics","securityTypeName":"DR","adrRate":"1:1"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LKFT\",market:\"US\",,,undefined,":{"directors":[{"name":"Henry Gosebruch","position":"Chief Executive Officer and Director"},{"name":"Jerome Contamine","position":"Chair of the Board"},{"name":"Dawn Svoronos","position":"Director"},{"name":"Devang Bhuva","position":"Director"},{"name":"Jane Griffiths","position":"Director"},{"name":"Linda Higgins","position":"Director"},{"name":"Neil Johnston","position":"Director"},{"name":"Oleg Nodelman","position":"Director"}],"executives":[{"name":"Henry Gosebruch","position":"Chief Executive Officer and Director"},{"name":"Aaron Cox","position":"Chief Financial Officer and Executive Vice President"},{"name":"Annelies Missotten","position":"Chief Human Resources Officer and Executive Vice President"},{"name":"Eric Hedrick","position":"Chief Medical Officer"},{"name":"Fred Blakeslee","position":"Executive Vice President and General Counsel"}]}}}